General Nurse Practitioner News

NP

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Sego S – Oral colloidal silver products are purported to be effective against viruses, bacteria, cancer, diabetes, and even HIV/AIDS. There are no clinical data to support these claims or validate the safety of colloidal silver use. Silver accumulation in body tissue can be fatal. Side effects from using products containing colloidal silver may include neurologic problems (e.g., seizures), kidney damage, stomach distress, headaches, fatigue, and skin irritation. The use of silver products must remain under the guidance of a clinician. The risk/benefit ratio of current colloidal silver products is a very poor gamble and one that clinicians should urge patients not to take. Given the surge in popularity of alternative therapies, the presence of products containing this supplement on the shelves of America's retail outlets is most unfortunate. There is no clinical indication for its use. Wound–care products containing silver are extremely useful in combating infections and must not be classified in the same category as colloidal silver. Colloidal silver is a product clinicians must be very clear about. Make sure patients understand its lack of utility and potential for danger.


Related Articles

Coffee Break: Compound Brewing New Research In Colon, Breast Cancer
ScienceDaily, 11/13/09    Relevance Score: 43%

Bioactive Compounds and Antioxidant and Antiproliferative Activities of Korean White Lotus Cultivars
Journal of Medicinal Food, 11/04/09    Relevance Score: 43%

Analysis of labelled compounds by mass spectroscopy in the presence of heavy isotopes at natural abundance: the NAIC program
Journal of Labelled Compounds and Radiopharmaceuticals, 10/09/09    Relevance Score: 43%

Nonaminoglycoside compounds induce readthrough of nonsense mutations
Journal of Experimental Medicine, 10/06/09    Relevance Score: 43%

SR 57746A/xaliproden, a non-peptide neurotrophic compound: prospects and constraints for the treatment of nervous system diseases
Expert Opinion on Investigational Drugs, 10/26/09    Relevance Score: 42%

Today in Complementary Medicine...keeping you current

Alternative Drug Therapies in LTC Facilities: A Guide to Definition, Policies, and Procedures
Annals of Long-Term Care, 03/22/10

Benefits of Yoga for African American Heart Failure Patients
Medicine and Science in Sports and Exercise, 03/19/10

Acupuncture for treating dry eye: a systematic review
Acta Ophthalmologica, 03/18/10

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address